This has an RVPH feel to it. The BE study was FDA guided and primary endpoint was met. FDA concluded no other studies are necessary for the NDA. Filing mid 2023. 40% insider ownership, 20% tutes. All looks extremely promising. I'm definitely holding.$Unicycive Therapeutics, Inc.(UNCY)$

Summary The evaluations for all 3,000+ including MSFT come from price range forecasts made daily by Market-Makers, far better than most non-pro investors when future stock prices are the question. There both Risk and Reward are seen the same way from one stock to another, seen as future changes in share prices. Ranked comparisons between stocks are accomplished by having actual market outcomes of prior forecasts for each stock which in prior times had the same risk-reward balances as today. MSFT is a stock regularly volume-traded, with daily-updated professional analyst price-range forecasts - surprises unlikely next few months. Extensive history of forecasts for MSFT is available for comparisons with self and with alternative investments at this time. Best defense often is a good offense.

From oilprice, ... commodity analysts at Standard Chartered warn that the oil price crash has been exacerbated by hedging activity–specifically, due to gamma hedging effects, with banks selling oil to manage their side of options as prices fall through the strike prices of oil producer put options and volatility increases. The negative price effect has been exacerbated because the main cliff-face of producer puts currently occupies a narrow price range...Apparently, one exits or hangs around holding their nuts waiting for better days, which most "experts" are predicting.$Occidental(OXY)$

This week will be sub 160. Earnings in less than a month. Projected to be bad. Berlin factory shut down and slow down in sales in china will accentuate the fall. How low ? I dont know. sub 160 for sure possibly sub 150. Correction is healthy especially for this overvalued retail pumped stock $Tesla Motors(TSLA)$

$Grab Holdings(GRAB)$ is -47.27% lower on its value in year-to-date trading and has touched a low of $2.26 and a high of $17.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GRAB stock was last observed hovering at around $3.68 in the last trading session, with the day’s gains setting it 0.08% off its average median price target of $4.22 for the next 12 months. It is also 53.0% off the consensus price target high of $8.00 offered by 22 analysts, but current levels are -64.19% lower than the price target low of $2.29 for the same period.Currently trading at $3.76, the stock is 22.78% an

$Alibaba(BABA)$ $Alibaba(09988)$ The investors interested in Chinese growth stocks have better opportunities at this point than BABA - a 23 year market leader. Not unlike AMZN in the US - was a great investment, but tough to expect more than average market returns going forward following its long dive

Zachs is one of the biggest bashers of AMD. AMD has been on its "Strong Sell" list since its price per share has been increasing dramatically. Why? Are they trying to help Short Sellers? If so, it's not working! AMD will prevail despite their futile attempts to get people to sell!$Advanced Micro Devices(AMD)$

$Pinterest, Inc.(PINS)$ Just can't win on this one. They've performed well in terms of financials for the past 3 quarters, but all the market seems to care about is user growth shrinking. It doesn't have too much room to drop, but to be honest, I think this is now worth more as an acquisition than a stand alone. I think we be in this $20 range now unless tech becomes favorable or someone buys it at $35 - $40/share.